Seguir
Debra Josephs MBChB, PhD, MRCP
Debra Josephs MBChB, PhD, MRCP
Consultant Medical Oncologist
Dirección de correo verificada de kcl.ac.uk
Título
Citado por
Citado por
Año
Targeting folate receptor alpha for cancer treatment
A Cheung, HJ Bax, DH Josephs, KM Ilieva, G Pellizzari, J Opzoomer, ...
Oncotarget 7 (32), 52553, 2016
2782016
IgG4 subclass antibodies impair antitumor immunity in melanoma
P Karagiannis, AE Gilbert, DH Josephs, N Ali, T Dodev, L Saul, I Correa, ...
The Journal of clinical investigation 123 (4), 1457-1474, 2013
1802013
Upregulation of the CD40/CD40 ligand dyad and platelet-monocyte aggregation in cigarette smokers
SA Harding, J Sarma, DH Josephs, NL Cruden, JN Din, PJ Twomey, ...
Circulation 109 (16), 1926-1929, 2004
1582004
Combining immune checkpoint inhibitors: established and emerging targets and strategies to improve outcomes in melanoma
DO Khair, HJ Bax, S Mele, S Crescioli, G Pellizzari, A Khiabany, ...
Frontiers in immunology 10, 453, 2019
1552019
Regional activation of myosin II in cancer cells drives tumor progression via a secretory cross-talk with the immune microenvironment
M Georgouli, C Herraiz, E Crosas-Molist, B Fanshawe, O Maiques, ...
Cell 176 (4), 757-774. e23, 2019
932019
Clinical pharmacokinetics of tyrosine kinase inhibitors: implications for therapeutic drug monitoring
DH Josephs, DS Fisher, J Spicer, RJ Flanagan
Therapeutic drug monitoring 35 (5), 562-587, 2013
872013
A tool kit for rapid cloning and expression of recombinant antibodies
TS Dodev, P Karagiannis, AE Gilbert, DH Josephs, H Bowen, LK James, ...
Scientific reports 4 (1), 1-10, 2014
862014
Antibody structure and engineering considerations for the design and function of Antibody Drug Conjugates (ADCs)
RM Hoffmann, BGT Coumbe, DH Josephs, S Mele, KM Ilieva, A Cheung, ...
Oncoimmunology 7 (3), e1395127, 2018
852018
Epidemiological associations of allergy, IgE and cancer
DH Josephs, JF Spicer, CJ Corrigan, HJ Gould, SN Karagiannis
Clinical & Experimental Allergy 43 (10), 1110-1123, 2013
842013
Effects of BRAF Mutations and BRAF Inhibition on Immune Responses to MelanomaBRAF Mutations and Immunity in Melanoma
KM Ilieva, I Correa, DH Josephs, P Karagiannis, IU Egbuniwe, ...
Molecular cancer therapeutics 13 (12), 2769-2783, 2014
802014
An automated method for the measurement of a range of tyrosine kinase inhibitors in human plasma or serum using turbulent flow liquid chromatography–tandem mass spectrometry
L Couchman, M Birch, R Ireland, A Corrigan, S Wickramasinghe, ...
Analytical and Bioanalytical Chemistry 403 (6), 1685-1695, 2012
772012
BRAF inhibitors: resistance and the promise of combination treatments for melanoma
M Griffin, D Scotto, DH Josephs, S Mele, S Crescioli, HJ Bax, G Pellizzari, ...
Oncotarget 8 (44), 78174, 2017
742017
Monitoring the systemic human memory B cell compartment of melanoma patients for anti-tumor IgG antibodies
AE Gilbert, P Karagiannis, T Dodev, A Koers, K Lacy, DH Josephs, ...
PloS one 6 (4), e19330, 2011
642011
AllergoOncology–the impact of allergy in oncology: EAACI position paper
E Jensen‐Jarolim, HJ Bax, R Bianchini, M Capron, C Corrigan, M Castells, ...
Allergy 72 (6), 866-887, 2017
622017
Tumour-associated macrophage polarisation and re-education with immunotherapy
DH Josephs, HJ Bax, SN Karagiannis
Front Biosci (Elite Ed) 7, 293-308, 2015
602015
Molecular imaging in clinical trials
D Josephs, J Spicer, M O’Doherty
Targeted oncology 4 (3), 151-168, 2009
592009
Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with severe renal impairment or on haemodialysis
D Josephs, TE Hutson, CL Cowey, LM Pickering, JM Larkin, ME Gore, ...
BJU international 108 (8), 1279-1283, 2011
572011
Recombinant IgE antibodies for passive immunotherapy of solid tumours: from concept towards clinical application
SN Karagiannis, DH Josephs, P Karagiannis, AE Gilbert, L Saul, ...
Cancer Immunology, Immunotherapy 61 (9), 1547-1564, 2012
562012
Factors affecting COVID-19 outcomes in cancer patients: a first report from guy's cancer center in London
B Russell, C Moss, S Papa, S Irshad, P Ross, J Spicer, S Kordasti, ...
Frontiers in oncology 10, 1279, 2020
542020
Anti-folate receptor alpha–directed antibody therapies restrict the growth of triple-negative breast cancer
A Cheung, J Opzoomer, KM Ilieva, P Gazinska, RM Hoffmann, H Mirza, ...
Clinical Cancer Research 24 (20), 5098-5111, 2018
532018
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20